JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2016, Vol. 54 ›› Issue (4): 68-73.doi: 10.6040/j.issn.1671-7554.0.2015.1011
Previous Articles Next Articles
SUN Xuyi, HAN Jiankui
CLC Number:
[1] Wang XL, Yang F, Jin C, et al. Utility of PET/CT in diagnosis, staging, assessment of resectability and metabolic response of pancreatic cancer[J]. World J Gastroenterol, 2014, 20(42): 15580-15589. [2] Bipat S, Phoa SS, van Delden OM, et al. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis[J]. J Comput Assist Tomogr, 2005, 29(4): 438-445. [3] Tang S, Huang G, Liu J, et al. Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: A meta-analysis[J]. European Journal of Radiology, 2011, 78(1): 142-150. [4] Lodge MA, Lucas JD, Marsden PK, et al. A PET study of 18FDG uptake in soft tissue masses[J]. Eur J Nucl Med, 1999, 26(1): 22-30. [5] Kawada N, Uehara H, Hosoki T, et al. Usefulness of Dual-Phase 18F-FDG PET/CT for Diagnosing Small Pancreatic Tumors[J]. Pancreas, 2015, 44(4): 655-659. [6] Nakamoto Y, Higashi T, Sakahara H, et al. Delayed(18)F-fluoro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas[J]. Cancer, 2000, 89(12): 2547-2554. [7] Rijkers AP, Valkema BR, Duivenvoorden HJ, et al. Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: A meta-analysis[J]. Eur J Surg Oncol, 2014, 40(7): 794-804. [8] Nishiyama Y, Yamamoto Y, Monden T, et al. Evaluation of delayed additional FDG PET imaging in patients with pancreatic tumour[J]. Nucl Med Commun, 2005, 26(10): 895-901. [9] Yoshioka M, Uchinami H, Watanabe G, et al. F-18 fluorodeoxyglucose positron emission tomography for differential diagnosis of pancreatic tumors[J]. Springerplus, 2015, 4: 154. [10] Friess H, Langhans J, Ebert M, et al. Diagnosis of pancreatic cancer by 2[18F] -fluoro-2-deoxy-D-glucose positron emission tomograpgy[J]. Gut, 1995, 36(5): 771-777. [11] Delbeke D, Martin WH. PET and PET/CT for pancreatic malignancies[J]. Surg Oncol Clin N Am, 2010, 19(2): 235-254. [12] Ozaki Y, Oguchi K, Hamano H, et al. Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography[J]. Gastroenterol, 2008, 43(2): 144-151. [13] Kamisawa T, Takum K, Anjiki H, et al. FDG-PET/CT findings of autoimmune pancreatitis[J]. Hepatogastroenterology, 2010, 57(99-100): 447-450. [14] Shigekawa M, Yamao K, Sawaki A, et a1. Is 18F-fluorodeoxyglueose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis?[J]. J Hepatobiliary Pancreat Sci, 2010, 17(3): 269-274. [15] Zimny M, Bares R, Fass J, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases[J]. Eur J Nucl Med, 1997, 24(6): 678-682. [16] von Forstner C, Egberts JH, Ammerpohl O, et al. Gene expression patterns and tumor uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an orthotopic mouse xenotransplantation model of pancreatic cancer[J]. J Nucl Med, 2008, 49(8): 1362-1370. |
[1] | XU Yujun, LIU Ming, HE Xiangmeng, LI Chengli. 1.0T open MRI-guided 125I seeds percutaneous implantation for advanced pancreatic cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(2): 21-25. |
[2] | GAO Ang, WANG Shijiang, FU Zheng, SUN Xindong, YU Jinming, MENG Xue. A feasibility study for boost target delineation using 18F-FDG PET/CT in local advanced non-small cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(7): 73-77. |
[3] | LI Hongxia, DONG Lei, JIANG Jiong, WANG Xinyang. Effects of peptide YY on apoptosis of human pancreatic cancer cell line Miapaca-2 in vitro [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(12): 7-11. |
[4] | LI Mei-ying1, LI Ji-sheng1, YU Xue-jun1, SUN Li-mei1, WANG Ai-jun1, LIU Qi-ji2, WANG Xiu-wen1. Effects of bufalin on the proliferation and cell cycle of human pancreatic cancer CAPAN-2 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(11): 37-41. |
[5] | ZHENG Hong-min. Expression of molealar imaging marker folate receptor alpha in pancreatic cancer and its significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(3): 83-85. |
[6] |
CUI Yazhou1, JIA Qing2, WANG Zhaopeng2, WANG Zhaoxia2, Polypeptide extract from scorpion venom inhibits |
|